The company will challenge this determination. The company exceeded the parameters it needed to satisfy for the trial outline.
It doesn't make sense to have certain clinical targets and then to change its mind.
This is crazy!!
Ann: CE Marking Update, page-8
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(3.57%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.4¢ | $42.77K | 3.056M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2181235 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 5929275 | 8 |
View Market Depth
| Last trade - 10.10am 01/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |